FindTrial
Sign In

3

DRUG5 trials

Sponsors

Ziekenhuis Aan De Stroom, Arq National Psychotrauma Centre, OM Pharma SA, Seoul National University Hospital

Conditions

Prostate cancerRecurrent wheezingRespiratory Tract Infections with Wheezing Lower Respiratory IllnessTinnitusposttraumatic stress disorder

Phase 2

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
RecruitingCTIS2022-501551-90-00
Ziekenhuis Aan De StroomProstate cancer
Start: 2023-12-13Target: 583Updated: 2026-01-23
High-Intensity Inpatient MDMA-Assisted Psychotherapy for Treatment-Refractory Posttraumatic Stress Disorder: An Open-Label Pilot Study
RecruitingCTIS2023-508229-28-00
Arq National Psychotrauma Centreposttraumatic stress disorder
Start: 2025-05-16Target: 20Updated: 2025-05-12
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo given in Children Aged 6 Months to 5 Years with Recurrent Wheezing
Active, not recruitingCTIS2024-511083-90-00
OM Pharma SARecurrent wheezing
Start: 2024-10-03Target: 85Updated: 2025-10-17

Phase 4

A Randomised, Placebo-Controlled, 3-Arm, Double-Blind, Multicentre, Phase 4 Study to Assess the Efficacy of OM-85 (Broncho Vaxom) Short- and Long-Term Treatment vs. Placebo in the Prevention of Respiratory Tract Infections in Children Aged Between 6 Months and 5 Years with Wheezing Lower Respiratory Illness
Active, not recruitingCTIS2024-511581-37-00
OM Pharma SARespiratory Tract Infections with Wheezing Lower Respiratory Illness
Start: 2022-11-25Target: 497Updated: 2025-12-10

Unknown Phase

Verify the Effectiveness rTMS Using MEG
NCT01874444
Seoul National University HospitalTinnitus
Start: 2013-05-31End: 2015-12-31Target: 28Updated: 2014-11-19